- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-26-0131696

Elet Pharma Private Limited
About Elet Pharma Private Limited
Data last updated:
Elet Pharma Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 11 January 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24290PN2021PTC197605. Its GSTIN is 09AAGCE2793K1Z5 (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Vishal Chandra and Sandeep Haldar.
Its last annual general meeting (AGM) was held on 19 July 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at S.No – 55/1/56/1 57/1 To 4 Elementra Defl B/D – 1/1206 Nearbalaji Education Tathawade, Pune, Maharashtra, India – 411033.
As per the financials filed for FY 2025, the company reported a revenue of ₹30.8 Lakh, a decline of 5% compared to the previous year. For the same year it recorded a net profit of ₹7,637 (net margin 0.2%) and EBITDA of ₹14,225 (EBITDA margin 0.5%).
Elet Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0131696).
Recognitions & Rankings of Elet Pharma
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressS.No – 55/1/56/1 57/1 To 4 Elementra Defl B/D – 1/1206 Nearbalaji Education Tathawade, Pune, Maharashtra, India – 411033
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Elet Pharma Private Limited
The main business activity of Elet Pharma is human health and social work activities. In detail, this covers human health activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Elet Pharma Private Limited FY 2025 filings available
Elet Pharma Private Limited reported revenue of ₹30.8 Lakh (down 5% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Elet Pharma Private Limited
Revenue fell 5% in the latest year. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Elet Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹14,225 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹7,637 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Elet Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Elet Pharma are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Elet Pharma Private Limited
Elet Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vishal Chandra | Director | 11 Jan 2021 | 5 Years 9 Months | Current |
| Sandeep Haldar | Director | 11 Jan 2021 | 5 Years 9 Months | Current |
| Sanjeev Kumar Haldar | Director | 11 Jan 2021 | 5 Years 9 Months | Current |
Peer Comparison of Elet Pharma Private Limited
Elet Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Human health activities). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sukhi Life Services (OPC) Private Limited | ₹30.97 Lakh (FY 2025) | •••• | •••• | 110.0% | •••• | Hyderabad, Telangana, India |
| Dr. Alexander Lab Private Limited | ₹30.89 Lakh (FY 2024) | •••• | •••• | 36.0% | •••• | Delhi, India |
| Urban Elite Medicare Foundation | ₹30.89 Lakh (FY 2025) | •••• | •••• | 23.0% | •••• | Shivaji Enclave, Delhi, India |
| Dentisti Healthtech Private Limited | ₹30.87 Lakh (FY 2025) | •••• | •••• | •••• | Kolkata, West Bengal, India | |
| Shree Rasamrita Ayurveda Private Limited | ₹30.83 Lakh (FY 2025) | •••• | •••• | •••• | Khetri, Rajasthan, India | |
| Elet Pharma Private Limited this company | ₹30.8 Lakh (FY 2025) | •••• | •••• | -5.0% | •••• | Pune, Maharashtra, India |
| SNS Trading Private Limited | ₹30.8 Lakh (FY 2024) | •••• | •••• | 269.0% | •••• | New Delhi, Delhi, India |
| Alnair Pharmaceutical Private Limited | ₹30.76 Lakh (FY 2025) | •••• | •••• | 27.0% | •••• | Bhosari, Maharashtra, India |
| Sunlight Healthcare Private Limited | ₹30.67 Lakh (FY 2025) | •••• | •••• | -94.0% | •••• | New Delhi, Delhi, India |
| Hi-Reach Hospitals Private Limited | ₹30.62 Lakh (FY 2025) | •••• | •••• | -11.0% | •••• | Chennai, Tamil Nadu, India |
| Senesco Pharma Private Limited | ₹30.59 Lakh (FY 2024) | •••• | •••• | •••• | Pune, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Elet Pharma by revenue in the same principal business activity (Human health activities), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Elet Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Elet Pharma Private Limited
Elet Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Elet Pharma Private Limited
Elet Pharma Private Limited has a workforce of 0 employees as of Mar 28, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Elet Pharma Private Limited
Elet Pharma Private Limited has 4 board changes on record since 2021: 3 appointments and 1 cessation. The latest: Surjeet Haldar ceased to be Director on 08 Jun 2021.
Credit Ratings, Litigation & Regulatory Alerts for Elet Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Elet Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Elet Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Elet Pharma Private Limited
Elet Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAGCE2793K1Z5 | Uttar Pradesh | Active | 16 Feb 2022 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Elet Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Elet Pharma Private Limited
Elet Pharma is an active private limited company based in Pune, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 11 January 2021 (5+ years old) and is registered under CIN U24290PN2021PTC197605.
Elet Pharma reported revenue of ₹30.8 Lakh for FY 2025 (down 5% YoY).
Elet Pharma has 3 current directors:
- Vishal Chandra - Director
- Sandeep Haldar - Director
- Sanjeev Kumar Haldar - Director
Elet Pharma reported a net profit of ₹7,637 (net margin 0.2%) and EBITDA of ₹14,225 (EBITDA margin 0.5%) for FY 2025, as per its filed financial statements.
The GSTIN of Elet Pharma is 09AAGCE2793K1Z5, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Elet Pharma is U24290PN2021PTC197605. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Elet Pharma was incorporated on 11 January 2021, making it 5+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Elet Pharma by revenue are Sukhi Life Services (OPC) Private Limited, Dr. Alexander Lab Private Limited, Urban Elite Medicare Foundation, Dentisti Healthtech Private Limited, Shree Rasamrita Ayurveda Private Limited and 5 more, all in the same principal business activity (Human health activities).
Surjeet Haldar ceased to be Director on 08 Jun 2021. Sandeep Haldar was appointed as Director on 11 Jan 2021. Sanjeev Kumar Haldar was appointed as Director on 11 Jan 2021. Elet Pharma has 4 board changes on record in total.
Yes, Elet Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-26-0131696).
The registered office of Elet Pharma is at S.No – 551561 571 To 4 Elementra Defl BD – 11206 Nearbalaji Education Tathawade, Pune, Maharashtra, India – 411033.